3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
38
Neoplasms
33
Depression
28
Fatigue
24
Prostatic Neoplasms
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Follicular
17
Multiple Myeloma
15
Lymphoma, Non-Hodgkin
14
Lymphoma, Mantle-Cell
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Burkitt Lymphoma
14
Lymphoma, B-Cell, Marginal Zone
13
Leukemia, Myeloid, Acute
13
Hodgkin Disease
13
Colorectal Neoplasms
13
Lymphoma, Large-Cell, Immunoblastic
12
Lung Neoplasms
12
Anxiety Disorders
12
Lymphoma
11
Leukemia, Myeloid, Chronic-Phase
11
Blast Crisis
11
Leukemia, Myeloid, Accelerated Phase
10
Recurrence
9
Pain
9
Lymphoma, T-Cell, Cutaneous
9
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
9
Leukemia, Hairy Cell
9
Leukemia
9
Interventions
Tobacco Use Cessation Devices
2
Surveys and Questionnaires
2
Nivolumab
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Electrocoagulation
2
Biopsy
2
fludarabine phosphate
1
fludarabine
1
Watchful Waiting
1
Trichloroacetic Acid
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Thiotepa
1
Therapeutics
1
Tacrolimus
1
Self Care
1
Ritonavir
1
Registries
1
Rapid Diagnostic Tests
1
Proctoscopy
1
Papillomavirus Vaccines
1
Occult Blood
1
Observation
1
Nevirapine
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Melphalan
1
Mass Screening
1
Mammography
1
Lopinavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Acquired Immunodeficiency Syndrome
×
Therapeutics
×
Clear all
NCT02615860
2022-11-08
TECAIN
University Hospital, Essen
Phase NA
Completed
560 enrolled